Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Laryngoscope. 2023 Jan;133(1):2-3. doi: 10.1002/lary.30180. Epub 2022 May 11.
No abstract available

MeSH terms

  • Bevacizumab / therapeutic use
  • Humans
  • Papillomavirus Infections* / drug therapy
  • Respiratory Tract Infections* / drug therapy

Substances

  • Bevacizumab

Supplementary concepts

  • Recurrent respiratory papillomatosis